Rapport Therapeutics Inc (RAPP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 56,910 | 70,254 | 31,159 |
| Marketable Securities | 248,475 | 77,309 | N/A |
| TOTAL | $309,802 | $150,872 | $31,268 |
| Non-Current Assets | |||
| PPE Net | 3,529 | 1,916 | 335 |
| Other Non-Current Assets | 1,602 | 2,635 | 0 |
| TOTAL | $5,131 | $4,551 | $335 |
| Total Assets | $314,933 | $155,423 | $31,603 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 1,954 | 2,502 | 1,450 |
| Accrued Expenses | 6,076 | 5,631 | 213 |
| TOTAL | $8,767 | $8,803 | $1,663 |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 739 | 5,676 | 10,435 |
| TOTAL | $739 | $5,676 | $10,435 |
| Total Liabilities | $9,506 | $14,479 | $12,098 |
| Shareholders' Equity | |||
| Shares Outstanding, K | 36,496 | N/A | N/A |
| Common Shares | 37 | 4 | 4 |
| Retained earnings | -123,745 | -45,438 | -10,652 |
| Other shareholders' equity | -522 | 166,582 | 29,567 |
| TOTAL | $305,427 | $140,944 | $19,505 |
| Total Liabilities And Equity | $314,933 | $155,423 | $31,603 |